144 related articles for article (PubMed ID: 6317238)
1. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
[TBL] [Abstract][Full Text] [Related]
2. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
[TBL] [Abstract][Full Text] [Related]
3. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
4. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
Shinomiya N; Yata J
Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
[TBL] [Abstract][Full Text] [Related]
5. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
Scadding GK; Calder L; Newsom-Davis J
Muscle Nerve; 1983; 6(9):656-60. PubMed ID: 6606776
[TBL] [Abstract][Full Text] [Related]
6. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
7. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
Newsom-Davis J; Willcox N; Calder L
N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
[TBL] [Abstract][Full Text] [Related]
8. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes.
Lisak RP; Levinson AI; Zweiman B; Kornstein MJ
J Immunol; 1986 Aug; 137(4):1221-5. PubMed ID: 3488346
[TBL] [Abstract][Full Text] [Related]
11. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
Hill ME; Shiono H; Newsom-Davis J; Willcox N
J Neuroimmunol; 2008 Sep; 201-202():50-6. PubMed ID: 18722675
[TBL] [Abstract][Full Text] [Related]
12. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
13. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
Fujii Y; Lindstrom J
J Immunol; 1988 Nov; 141(10):3361-9. PubMed ID: 2972772
[TBL] [Abstract][Full Text] [Related]
14. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
16. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
[TBL] [Abstract][Full Text] [Related]
17. Thyroid autoantibody synthesis by lymphocytes from different lymphoid organs: fractionation of B cells on density gradients.
Atherton MC; McLachlan SM; Pegg CA; Dickinson A; Baylis P; Young ET; Proctor SJ; Rees Smith B
Immunology; 1985 Jun; 55(2):271-9. PubMed ID: 4007928
[TBL] [Abstract][Full Text] [Related]
18. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
Xiao BG; Duan RS; Zhu WH; Lu CZ
Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholine receptor antibody synthesis in lymphocyte cultures.
McLachlan SM; Nicholson LV; Venables G; Mastalgia FL; Bates D; Smith BR; Hall R
J Clin Lab Immunol; 1981 May; 5(3):137-42. PubMed ID: 7241564
[TBL] [Abstract][Full Text] [Related]
20. The role of B-cells in experimental myasthenia gravis in mice.
Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
